CAS 52157-91-2
:Galosemida
- Galosemide [INN]
- Gallosemide
- Brn 0501125
- C 2124
- Galosemida
- Galosemida [INN-Spanish]
- Galosemidum
- Galosemidum [INN-Latin]
- N-((4-((3-(Trifluoromethyl)phenyl)amino)-3-pyridinyl)sulfonyl)propanamide
- N-((4-(alpha,alpha,alpha-Trifluoro-3-toluidino)-3-pyridyl)sulfonyl)propionamid
- N-((4-(alpha,alpha,alpha-Trifluoro-m-toluidino)-3-pyridyl)sulfonyl)propionamide
- Unii-J8Qb2W9908
- Propanamide, N-((4-((3-(trifluoromethyl)phenyl)amino)-3-pyridinyl)sulfonyl)-
- N-[(4-{[3-(trifluoromethyl)phenyl]amino}pyridin-3-yl)sulfonyl]propanamide
- 5-22-14-00461 (Beilstein Handbook Reference)
- Galosemide
- N-[4-[3-(trifluoromethyl)anilino]pyridin-3-yl]sulfonylpropanamide
- N-[4-[[3-(trifluoromethyl)phenyl]amino]pyridin-3-yl]sulfonylpropanamide
- Ver mais sinónimos
Galosemide
CAS:Produto ControladoApplications Galosemide is a compound with diuretic activity.
References Delarge, J., Ghys, A.: Ann Pharm Fr, 39, 59 (1981);Fórmula:C15H14F3N3O3SCor e Forma:NeatPeso molecular:373.35Galosemide
CAS:Galosemide is a drug that belongs to the class of organic acids. It is used in the treatment of congestive heart failure and hypertension. This drug binds to specific target proteins, which are present in the heart muscle cells, to lower blood pressure by preventing arrhythmia. The trifluoromethyl group on galosemide allows it to bind with high affinity and specificity to these target proteins. Galosemide also has been shown to affect cardiac metabolism by lowering levels of lipids (dyslipidemia) and reducing ventricular dysfunction due to its ability to decrease cardiac energy consumption. Galosemide may be administered orally or intravenously as a reconstituted solution. It can be diluted with water for injection or mixed with other diluents such as glucose, mannitol, dextrose, or sodium chloride for oral use.
Fórmula:C15H14F3N3O3SPureza:Min. 95%Peso molecular:373.4 g/mol

